NT$
25.70
Apr 22
Current and historical daily PE Ratio for Chi Sheng Pharma & Biotech Co Ltd (
) from 1999 to Apr 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Chi Sheng Pharma & Biotech stock (ROCO:4111) PE ratio as of Apr 23 2024 is 12.73.
More Details
Chi Sheng Pharma & Biotech Co Ltd (ROCO:4111) PE Ratio (TTM) Chart
Chi Sheng Pharma & Biotech Co Ltd (ROCO:4111) PE Ratio (TTM) Historical Data
View and export this data going back to 1999. Start your Free Trial
Total 1175
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Chi Sheng Pharma & Biotech PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-04-23 | 12.7 | 2024-02-15 | 12.8 |
2024-04-22 | 12.7 | 2024-02-05 | 12.8 |
2024-04-19 | 12.8 | 2024-02-02 | 12.9 |
2024-04-18 | 13.0 | 2024-02-01 | 12.9 |
2024-04-17 | 13.1 | 2024-01-31 | 12.9 |
2024-04-16 | 13.0 | 2024-01-30 | 12.8 |
2024-04-15 | 13.0 | 2024-01-29 | 12.9 |
2024-04-12 | 13.1 | 2024-01-26 | 12.8 |
2024-04-11 | 13.1 | 2024-01-25 | 12.7 |
2024-04-10 | 13.2 | 2024-01-24 | 12.7 |
2024-04-09 | 13.2 | 2024-01-23 | 12.7 |
2024-04-08 | 13.0 | 2024-01-22 | 12.7 |
2024-04-03 | 13.0 | 2024-01-19 | 12.7 |
2024-04-02 | 13.1 | 2024-01-18 | 12.7 |
2024-04-01 | 13.1 | 2024-01-17 | 12.7 |
2024-03-29 | 13.0 | 2024-01-16 | 12.9 |
2024-03-28 | 13.0 | 2024-01-15 | 12.9 |
2024-03-27 | 13.0 | 2024-01-12 | 12.9 |
2024-03-26 | 12.9 | 2024-01-11 | 12.9 |
2024-03-25 | 12.9 | 2024-01-10 | 12.8 |
2024-03-22 | 12.9 | 2024-01-09 | 12.9 |
2024-03-21 | 12.8 | 2024-01-08 | 13.0 |
2024-03-20 | 12.9 | 2024-01-05 | 13.0 |
2024-03-19 | 12.9 | 2024-01-04 | 13.1 |
2024-03-18 | 12.9 | 2024-01-03 | 13.1 |
2024-03-15 | 12.9 | 2024-01-02 | 13.1 |
2024-03-14 | 12.9 | 2024-01-01 | 13.2 |
2024-03-13 | 12.9 | 2023-12-29 | 13.2 |
2024-03-12 | 12.9 | 2023-12-28 | 13.1 |
2024-03-11 | 12.8 | 2023-12-27 | 13.2 |
2024-03-08 | 12.9 | 2023-12-26 | 13.2 |
2024-03-07 | 12.9 | 2023-12-25 | 13.1 |
2024-03-06 | 12.9 | 2023-12-22 | 13.2 |
2024-03-05 | 13.0 | 2023-12-21 | 13.2 |
2024-03-04 | 12.9 | 2023-12-20 | 13.3 |
2024-03-01 | 13.0 | 2023-12-19 | 13.3 |
2024-02-29 | 13.0 | 2023-12-18 | 13.3 |
2024-02-27 | 13.0 | 2023-12-15 | 13.2 |
2024-02-26 | 13.0 | 2023-12-14 | 13.2 |
2024-02-23 | 12.9 | 2023-12-13 | 13.2 |
2024-02-22 | 13.0 | 2023-12-12 | 13.2 |
2024-02-21 | 13.1 | 2023-12-11 | 13.2 |
2024-02-20 | 13.0 | 2023-12-08 | 13.1 |
2024-02-19 | 13.0 | 2023-12-07 | 13.2 |
2024-02-16 | 13.0 | 2023-12-06 | 13.3 |
Chi Sheng Pharma & Biotech Co Ltd (ROCO:4111) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Chi Sheng Pharma & Biotech Co Ltd
NAICS : 339112
SIC : 3841
ISIN : TW0004111000
Description